Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study

American Journal of Kidney Diseases

Volumn 69, Issue 2, 2017, Pages 228-236

  Ballew, Shoshana H ^a   Chen, Yan ^a   Daya, Natalie R ^a   Godino, Job G ^b   Windham, B Gwen ^c   McAdams DeMarco, Mara ^a   Coresh, Josef ^a   Selvin, Elizabeth ^a   Grams, Morgan E ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

albuminuria; biomarker; chronic kidney disease (CKD); estimated glomerular filtration rate (eGFR); frail; Frailty; geriatric; older adults; polypharmacy; prefrail; reduced kidney function; serum creatinine; serum cystatin C; urine albumin

Indexed keywords

CREATININE; CYSTATIN C; DIGOXIN; HEMOGLOBIN A1C; HYPNOTIC AGENT; HYPNOTIC SEDATIVE AGENT; METFORMIN; BIOLOGICAL MARKER;

AGED; ALBUMINURIA; ANEMIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; ESTIMATED GLOMERULAR FILTRATION RATE; EXHAUSTION; FEMALE; FRAILTY; HEMATOLOGICAL PARAMETERS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; POLYPHARMACY; PROSPECTIVE STUDY; SLOWNESS; URINE ALBUMIN CREATININE RATIO; UROGENITAL SYSTEM PARAMETERS; WEAKNESS; WEIGHT REDUCTION; FRAIL ELDERLY; INDEPENDENT LIVING; KIDNEY; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; RISK FACTOR; URINE;

AGED; ALBUMINURIA; ATHEROSCLEROSIS; BIOMARKERS; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; FRAIL ELDERLY; HUMANS; INDEPENDENT LIVING; KIDNEY; KIDNEY FUNCTION TESTS; MALE; POLYPHARMACY; RISK FACTORS;

EID: 85006967907     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.08.034     Document Type: Article

References (46)

1. 1 Fried, L.P., Tangen, C.M., Walston, J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:3 (2001), M146–M156.
2. 2 Bandeen-Roche, K., Seplaki, C.L., Huang, J., et al. Frailty in older adults: a nationally representative profile in the United States. J Gerontol A Biol Sci Med Sci 70:11 (2015), 1427–1434.
3. 3 Zaslavsky, O., Cochrane, B.B., Thompson, H.J., Woods, N.F., Herting, J.R., LaCroix, A., Frailty: a review of the first decade of research. Biol Res Nurs 15:4 (2013), 422–432.
4. 4 Shamliyan, T., Talley, K.M., Ramakrishnan, R., Kane, R.L., Association of frailty with survival: a systematic literature review. Ageing Res Rev 12:2 (2013), 719–736.
5. 5 Hubbard, R.E., O'Mahony, M.S., Woodhouse, K.W., Medication prescribing in frail older people. Eur J Clin Pharmacol 69:3 (2013), 319–326.
6. 6 Kantor, E.D., Rehm, C.D., Haas, J.S., Chan, A.T., Giovannucci, E.L., Trends in prescription drug use among adults in the United States from 1999-2012. JAMA 314:17 (2015), 1818–1831.
7. 7 Coresh, J., Selvin, E., Stevens, L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298:17 (2007), 2038–2047.
8. 8 Hallan, S.I., Coresh, J., Astor, B.C., et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17:8 (2006), 2275–2284.
9. 9 Dalrymple, L.S., Katz, R., Rifkin, D.E., et al. Kidney function and prevalent and incident frailty. Clin J Am Soc Nephrol 8:12 (2013), 2091–2099.
10. 10 Shlipak, M.G., Stehman-Breen, C., Fried, L.F., et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 43:5 (2004), 861–867.
11. 11 Bowling, C.B., Muntner, P., Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. J Gerontol A Biol Sci Med Sci 67:12 (2012), 1379–1386.
12. 12 Walker, S.R., Brar, R., Eng, F., et al. Frailty and physical function in chronic kidney disease: the CanFIT study. Can J Kidney Health Dis, 2, 2015, 32.
13. 13 Wilhelm-Leen, E.R., Hall, Y.N., Tamura, M.K., Chertow, G.M., Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med 122:7 (2009), 664–671.e662.
14. 14 Bohm, C., Storsley, L., Tangri, N., The assessment of frailty in older people with chronic kidney disease. Curr Opin Nephrol Hypertens 24:6 (2015), 498–504.
15. 15 Chang, S.S., Weiss, C.O., Xue, Q.L., Fried, L.P., Association between inflammatory-related disease burden and frailty: results from the Women's Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr 54:1 (2012), 9–15.
16. 16 Roshanravan, B., Khatri, M., Robinson-Cohen, C., et al. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 60:6 (2012), 912–921.
17. 17 Reese, P.P., Cappola, A.R., Shults, J., et al. Physical performance and frailty in chronic kidney disease. Am J Nephrol 38:4 (2013), 307–315.
18. 18 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 1 (2013), 1–150.
19. 19 Kucharska-Newton, A., Palta, P., Burgard, S., et al. Operationalizing frailty in the Atherosclerosis Risk in Communities (ARIC) Study cohort. J Gerontol A Biol Sci Med Sci, 2016, 10.1093/gerona/glw144.
20. 20 Radloff, L.S., The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:3 (1977), 385–401.
21. 21 Kohout, F.J., Berkman, L.F., Evans, D.A., Cornoni-Huntley, J., Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health 5:2 (1993), 179–193.
22. 22 Baecke, J.A., Burema, J., Frijters, J.E., A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:5 (1982), 936–942.
23. 23 Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:9 (2009), 604–612.
24. 24 Inker, L.A., Eckfeldt, J., Levey, A.S., et al. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis 58:4 (2011), 682–684.
25. 25 Grubb, A., Blirup-Jensen, S., Lindstrom, V., et al. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 48:11 (2010), 1619–1621.
26. 26 World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Vitamin and Mineral Nutrition Information System. WHO reference number: WHO/NMH/NHD/MNM/11.1, 2011, World Health Organization, Geneva, Switzerland.
27. 27 Garcia-Esquinas, E., Graciani, A., Guallar-Castillon, P., Lopez-Garcia, E., Rodriguez-Manas, L., Rodriguez-Artalejo, F., Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults. J Am Med Dir Assoc 16:9 (2015), 748–754.
28. 28 Pencina, M.J., D'Agostino, R.B. Sr., D'Agostino, R.B. Jr., Vasan, R.S., Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:2 (2008), 157–172 discussion 207-212.
29. 29 Shlipak, M.G., Matsushita, K., Arnlov, J., et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369:10 (2013), 932–943.
30. 30 Matsushita, K., van der Velde, M., Astor, B.C., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:9731 (2010), 2073–2081.
31. 31 Gansevoort, R.T., Matsushita, K., van der Velde, M., et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80:1 (2011), 93–104.
32. 32 Daya, N.R., Voskertchian, A., Schneider, A.L., et al. Kidney function and fracture risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 67:2 (2016), 218–226.
33. 33 Hallan, S.I., Matsushita, K., Sang, Y., et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 308:22 (2012), 2349–2360.
34. 34 Walker, S.R., Wagner, M., Tangri, N., Chronic kidney disease, frailty, and unsuccessful aging: a review. J Ren Nutr 24:6 (2014), 364–370.
35. 35 Chaves, P.H., Semba, R.D., Leng, S.X., et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 60:6 (2005), 729–735.
36. 36 Pires Corona, L., Drumond Andrade, F.C., de Oliveira Duarte, Y.A., Lebrao, M.L., The relationship between anemia, hemoglobin concentration and frailty in Brazilian older adults. J Nutr Health Aging 19:9 (2015), 935–940.
37. 37 Gnjidic, D., Hilmer, S.N., Blyth, F.M., et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharm Ther 91:3 (2012), 521–528.
38. 38 Bennett, A., Gnjidic, D., Gillett, M., et al. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging 31:3 (2014), 225–232.
39. 39 Crentsil, V., Ricks, M.O., Xue, Q.L., Fried, L.P., A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 8:3 (2010), 215–224.
40. 40 Jette, N., Lix, L.M., Metge, C.J., Prior, H.J., McChesney, J., Leslie, W.D., Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol 68:1 (2011), 107–112.
41. 41 Vestergaard, P., Rejnmark, L., Mosekilde, L., Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:6 (2006), 807–816.
42. 42 Ensrud, K.E., Blackwell, T., Mangione, C.M., et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163:8 (2003), 949–957.
43. 43 Buehring, B., Viswanathan, R., Binkley, N., Busse, W., Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol 132:5 (2013), 1019–1030.
44. 44 Ho, P., Brooy, B.L., Hayes, L., Lim, W.K., Direct oral anticoagulants in frail older adults: a geriatric perspective. Semin Thromb Hemost 41:4 (2015), 389–394.
45. 45 Buta, B.J., Walston, J.D., Godino, J.G., et al. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev 26 (2016), 53–61.
46. 46 US Food and Drug Administration. FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function. April 8, 2016. http://www.fda.gov/Drugs/DrugSafety/ucm493244.htm. Accessed July 12, 2016.